Project Description

Cloneshouse contributed to the Nigeria Zero-Dose Learning Hub initiative, supporting the development of a national learning agenda to address immunization equity and reduce the number of zero-dose children in Nigeria. The engagement was implemented between 2023 and 2025 as part of a multi-partner effort coordinated under the Zero-Dose Learning Hub (ZDLH) supported by Gavi – The Vaccine Alliance, in collaboration with national and international partners including the National Primary Health Care Development Agency (NPHCDA), Africa Health Budget Network (AHBN), African Field Epidemiology Network (AFENET), UNICEF, and other stakeholders. The assignment combined research collaboration, stakeholder engagement, and analytical contributions to the development of a national learning agenda that informs strategies to reach children who have not received routine immunization services.

Under this engagement, Cloneshouse contributed technical expertise to the evidence-generation process and stakeholder consultations that informed the learning agenda. The work included participation in consultations and analytical discussions that informed the design and prioritization of research questions focused on immunization equity and access. The engagement culminated in a national stakeholder consensus workshop in Abuja, where government institutions, civil society organizations, research partners, and development agencies collaboratively identified priority learning questions to guide operational research and programmatic improvements in Nigeria’s immunization system.

The project’s geographic scope focused on priority states with significant numbers of zero-dose children and persistent barriers to routine immunization coverage. These included Bauchi, Borno, Kano, and Sokoto States, while the national-level coordination and stakeholder engagement activities were conducted in Abuja. Through these engagements, Cloneshouse contributed to the analysis of systemic barriers affecting immunization access, including service delivery constraints, community-level demand factors, and health system performance challenges across the selected states.

Across the research and dissemination stages, Cloneshouse supported the synthesis of evidence and the articulation of a prioritized learning agenda that informs future research and program design aimed at reducing immunization inequities. The outputs of this collaborative effort were disseminated through academic and policy channels, including publication in the Nigerian Medical Journal. Through this work, Cloneshouse contributed to strengthening the evidence base guiding Nigeria’s efforts to reach underserved populations and accelerate progress toward ending zero-dose children by 2030.